Search

Search Constraints

You searched for: Author/Creator Reuben, Alexandre

Search Results

1. 672 Identification of microbial-derived HLA-bound peptides in melanoma. (9th November 2020)

2. 672 Identification of microbial-derived HLA-bound peptides in melanoma. (9th November 2020)

3. A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma. (4th May 2018)

4. Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018)

5. Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes. Issue 2 (2nd February 2022)

6. Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab. (2nd December 2017)

7. Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma. (3rd March 2016)

8. Gene expression profiling of lichenoid dermatitis immune‐related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response. (11th April 2019)

9. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. Issue 2 (17th November 2020)

10. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. Issue 2 (17th November 2020)